Carlsmed, Inc. CARL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.86% | -0.96% | -1.02% | -26.01% | -18.10% |
| Total Depreciation and Amortization | 31.31% | 1.02% | 19.51% | 34.43% | 52.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.94% | 80.65% | 3.56% | -1.91% | 109.39% |
| Change in Net Operating Assets | 89.82% | -534.82% | 210.12% | 18.94% | 41.91% |
| Cash from Operations | 43.43% | -144.45% | 37.10% | -20.12% | 13.65% |
| Capital Expenditure | -53.16% | -8.22% | 54.09% | 51.38% | -293.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15,282.68% | 99.47% | -13,028.80% | 46.67% | -122.58% |
| Cash from Investing | -9,442.23% | 99.15% | -6,964.14% | 48.96% | -182.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -44.27% | 1,976.19% | -99.98% | 274,800.00% | -77.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 98.19% | -21.18% | -519.57% |
| Cash from Financing | -44.27% | 1,603.45% | -100.03% | 4,138.42% | -119.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.53% | 56.81% | -136.12% | 922.30% | -401.18% |